111 Announced Receipt Of Withdrawal Of Going Private Proposal
111 Announced Receipt Of Withdrawal Of Going Private Proposal
111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it has received a notice dated Feburary 27, 2024 on behalf of the consortium comprising Dr. Gang Yu, co-founder and co-chairman of the Company, Mr. Junling Liu, co-founder, co-chairman and chief executive officer of the Company and certain other investors (collectively, the "Consortium"), stating that the Consortium would withdraw its preliminary non-binding going private proposal dated September 9, 2022 and preliminary non-binding going private proposal dated October 29, 2022 (collectively, the "Proposals"). The Consortium will formally terminate further negotiation with the special committee of the Company's board of directors regarding the transactions as contemplated by the Proposals.
111, Inc.（“111” 或 “公司”）（纳斯达克股票代码：YI）是一家领先的科技型医疗保健平台公司，致力于以数字方式将中国患者与医疗保健服务联系起来。该公司今天宣布，它已收到2024年2月27日代表该财团发出的通知，该财团由公司联合创始人兼联席董事长余刚博士、公司联合创始人、联席董事长兼首席执行官刘俊岭先生以及其他一些人组成投资者 (统称 “财团”) 表示, 该集团将撤回其初步的非强制性声明,2022年9月9日的具有约束力的私有化提案和2022年10月29日的初步非约束性私有化提案（统称为 “提案”）。该财团将正式终止与公司董事会特别委员会就提案所设想的交易进行的进一步谈判。